DXM Panel Proposes Augmenting, Improving Education To Curb Abuse
This article was originally published in The Tan Sheet
Executive Summary
Members of an FDA panel tipped their hats to the Consumer Healthcare Product Association's efforts to reduce dextromethorphan abuse, but floated enhancements to the program
You may also be interested in...
Another State Age-Restricts Sales Of DXM OTC Drugs As Teens' Abuse Of Ingredient Grows
Percentage of 10th- and 12th-graders in MTF survey using DXM-containing OTCs for inebriation effects had declined while rate of 8th-graders increased from 2018 to 2019. However, abuse of OTC drugs containing the cough suppressant increased in all age groups in 2020 survey.
OTC Pseudoephedrine Purchases In Arkansas Require In-State Identification
An Arkansas law limits sales of pseudoephedrine-containing OTC products to consumers with in-state identification, pioneering a tactic in states' attempts to curb illegal purchases.
CHPA Splits Roles Of Government Affairs VP, General Counsel And Secretary
Long-time drug industry lobbyist Bill Head will take over as VP of government affairs at the Consumer Healthcare Products Association following Andrew Fish's recent departure.